Experts are excitedly focused on retatrutide, a innovative drug from Eli Lilly, as a significant breakthrough in weight loss . Different than many earlier approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, chemicals that influence satiety and blood glucose r